Reduced Abdominal Aortic Aneurysm Growth Rate in Diabetic Patients Treated by Metformin: A Potential Role of Chemokines?

Ann Vasc Surg. 2021 Jan:70:e1-e2. doi: 10.1016/j.avsg.2020.07.015. Epub 2020 Jul 29.

Authors

Juliette Raffort¹, Fabien Lareyre²

Affiliations

¹ Clinical Chemistry Laboratory, University Hospital of Nice, Nice, France; Université Côte d'Azur, CHU, CNRS, Inserm U1065, C3M Nice, Nice, France. Electronic address: juliette.raffort@hotmail.fr.
² Université Côte d'Azur, CHU, Inserm U1065, C3M Nice, Nice, France; Department of Vascular Surgery, University Hospital of Nice and Antibes-Juan-les-Pins, Nice, France.

PMID: 32736029
DOI: 10.1016/j.avsg.2020.07.015

No abstract available

Publication types

Letter
Comment

MeSH terms

Aortic Aneurysm, Abdominal*
Chemokines
Diabetes Mellitus*
Humans
Metformin*
Treatment Outcome

Substances

Chemokines
Metformin